Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound
NCT ID: NCT07147270
Last Updated: 2025-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-05-01
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pleural Bleomycin vs Mechanical Abrasion in Malignant Pleural Effusion
NCT06691009
Pleural Tissue Culture Versus Pleural Fluid Culture in Infected Effusion
NCT07140003
Fluid Agitation Microbiologic Yield In Pleural Infection Feasibility Study
NCT05702580
A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion
NCT02583282
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
NCT00978939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Meanwhile, the oral forms of doxycycline are readily available, inexpensive and as effective as its parenteral forms in inducing pleurodesis. Therefore it will be used, aiming to assess the efficacy, safety and outcome of pleurodesis with and without patient rotation using doxycycline in malignant pleural effusion. Rotation of patients during tetracycline pleurodesis has been a common practice even at the moment. However, it had been proven that intrapleural instillation of parental tetracycline, a water soluble substance, to achieve chemical pleurodesis does not require rotation of patients as the tetracycline is distributed completely throughout the pleural space within seconds, and the distribution is not enhanced by patient's rotation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no rotation after pleurodesis
No interventions assigned to this group
rotation after pleurodesis
side to side and front to back rotation 30 minutes each
side to side and front to back rotation 30 minutes each after pleurodesis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
side to side and front to back rotation 30 minutes each
side to side and front to back rotation 30 minutes each after pleurodesis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous failed pleurodesis
* Liver failure
* Renal failure
* Congestive heart failure
* Prolonged use of steroids or NSAIDs
* Refusal to participate
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hieba gamal ezz-elragal awad
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ahmed M Abdelsamad
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fatema S Ebeid
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU R107/2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.